OTC Markets EXMKT - Delayed Quote USD
DNAPrint Genomics, Inc. (DNAG)
0.0000
0.0000
(0.00%)
At close: April 22 at 4:00:00 PM EDT
Breakdown
TTM
Total Revenue
1,931.2080
Cost of Revenue
1,484.8390
Gross Profit
446.3690
Operating Expense
6,752.5000
Operating Income
-6,306.1310
Other Income Expense
2,338.9260
Net Income Common Stockholders
-4,550.7940
Diluted NI Available to Com Stockholders
-4,550.7940
Basic EPS
-0.01
Diluted EPS
-0.01
Basic Average Shares
530,838.2780
Diluted Average Shares
530,838.2780
Total Operating Income as Reported
6,306.1310
Total Expenses
8,237.3390
Net Income from Continuing & Discontinued Operation
-4,550.7940
Normalized Income
-6,889.7200
EBIT
-6,306.1310
EBITDA
-5,491.5850
Reconciled Cost of Revenue
1,176.3830
Reconciled Depreciation
814.5460
Net Income from Continuing Operation Net Minority Interest
-4,550.7940
Total Unusual Items Excluding Goodwill
2,338.9260
Total Unusual Items
2,338.9260
Normalized EBITDA
-7,830.5110
8/26/57279 - 6/13/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MRPI Mera Pharmaceuticals, Inc.
0.0001
0.00%
MYMX Mymetics Corporation
0.0003
0.00%
SPPH Spencer Pharmaceutical Inc.
0.0001
0.00%
AIBT Aibotics Inc.
0.0130
-7.14%
RSPI RespireRx Pharmaceuticals Inc.
0.0017
0.00%
TXTM ProText Mobility, Inc.
0.0008
0.00%
SYRS Syros Pharmaceuticals, Inc.
0.0265
-8.30%
CVM CEL-SCI Corporation
0.2730
+4.52%
CTMX CytomX Therapeutics, Inc.
0.7361
-1.84%
ANVS Annovis Bio, Inc.
1.4700
+8.89%